PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma

Targeted combined immunotherapy has significantly improved the prognosis of patients with advanced hepatocellular carcinoma and has now become the primary treatment for advanced hepatocellular carcinoma. However, some patients still have poor efficacy or are resistant to treatment. The further explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yinkui, Qiu, Xiusheng, Wu, Donghao, Lu, Xu, Li, Guanghui, Tang, Yongsheng, Jia, Changchang, Xiong, Zhiyong, Wang, Tiantian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498926/
https://www.ncbi.nlm.nih.gov/pubmed/36140703
http://dx.doi.org/10.3390/genes13091535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498926/
https://www.ncbi.nlm.nih.gov/pubmed/36140703
http://dx.doi.org/10.3390/genes13091535

Ejemplares similares